Literature DB >> 34510292

Multi-auxiliary domain transfer learning for diagnosis of MCI conversion.

Bo Cheng1,2, Bingli Zhu3, Shuchang Pu4.   

Abstract

In the early stage of Alzheimer's disease (AD), mild cognitive impairment (MCI) has a higher risk of progression to AD, so the prediction of whether an MCI subject will progress to AD (known as progressive MCI, PMCI) or not (known as stable MCI, SMCI) within a certain period is particularly important in practice. It is known that such a task could benefit from jointly learning-related auxiliary tasks such as differentiating AD from PMCI or PMCI from normal control (NC) in order to take full advantage of their shared commonality. However, few existing methods along this line fully consider the correlations between the target and auxiliary tasks according to the clinical practice of AD pathology for diagnosis. To deal with this problem, in this paper, treating each task domain as a different one, we borrow the idea from transfer learning and propose a novel multi-auxiliary domain transfer learning (MaDTL) method, which explicitly utilizes the correlations between the target domain (task) and multi-auxiliary domains (tasks) according to the clinical practice. Specifically, the proposed MaDTL method incorporates two key modules. The first one is a multi-auxiliary domain transfer-based feature selection (MaDTFS) model, which can select a discriminative feature subset shared by the target domain and the multi-auxiliary domains. In the MaDTFS model, to combine more training data from multi-auxiliary domains and simultaneously suppress the negative effects resulting from the irrelevant parts of multi-auxiliary domains, we proposed a sparse group correlation Lasso that includes a proposed group correlation Lasso penalty (i.e., [Formula: see text]) and a proposed correlation Lasso penalty (i.e., [Formula: see text]). The second module in MaDTL is a multi-auxiliary domain transfer-based classification (MaDTC) model that improves the voting with linear weighting-based ensemble learning. This model extends the constraints of the linear weighting method so that it can simultaneously combine training data from multi-auxiliary domains and achieve a robust classifier by minimizing negative effects from the irrelevant part of multi-auxiliary domains. Experimental results on 409 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database with the baseline magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) data validate the effectiveness of the proposed method by significantly improving the classification accuracy to 80.37% for the identification of MCI-to-AD conversion, outperforming the state-of-the-art methods.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Alzheimer’s disease; Feature selection; Mild cognitive impairment; Multi-auxiliary domain; Transfer learning

Mesh:

Year:  2021        PMID: 34510292     DOI: 10.1007/s10072-021-05568-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  40 in total

1.  Multi-Domain Transfer Learning for Early Diagnosis of Alzheimer's Disease.

Authors:  Bo Cheng; Mingxia Liu; Dinggang Shen; Zuoyong Li; Daoqiang Zhang
Journal:  Neuroinformatics       Date:  2017-04

2.  Large scale deep learning for computer aided detection of mammographic lesions.

Authors:  Thijs Kooi; Geert Litjens; Bram van Ginneken; Albert Gubern-Mérida; Clara I Sánchez; Ritse Mann; Ard den Heeten; Nico Karssemeijer
Journal:  Med Image Anal       Date:  2016-08-02       Impact factor: 8.545

3.  Multimodal classification of Alzheimer's disease and mild cognitive impairment.

Authors:  Daoqiang Zhang; Yaping Wang; Luping Zhou; Hong Yuan; Dinggang Shen
Journal:  Neuroimage       Date:  2011-01-12       Impact factor: 6.556

4.  Deep ensemble learning of sparse regression models for brain disease diagnosis.

Authors:  Heung-Il Suk; Seong-Whan Lee; Dinggang Shen
Journal:  Med Image Anal       Date:  2017-01-24       Impact factor: 8.545

5.  Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment.

Authors:  Qing Li; Xia Wu; Lele Xu; Kewei Chen; Li Yao; Rui Li
Journal:  Comput Methods Programs Biomed       Date:  2017-07-18       Impact factor: 5.428

6.  Robust multi-label transfer feature learning for early diagnosis of Alzheimer's disease.

Authors:  Bo Cheng; Mingxia Liu; Daoqiang Zhang; Dinggang Shen
Journal:  Brain Imaging Behav       Date:  2019-02       Impact factor: 3.978

7.  Modeling Alzheimer's disease cognitive scores using multi-task sparse group lasso.

Authors:  Xiaoli Liu; André R Goncalves; Peng Cao; Dazhe Zhao; Arindam Banerjee
Journal:  Comput Med Imaging Graph       Date:  2017-12-05       Impact factor: 4.790

8.  A novel relational regularization feature selection method for joint regression and classification in AD diagnosis.

Authors:  Xiaofeng Zhu; Heung-Il Suk; Li Wang; Seong-Whan Lee; Dinggang Shen
Journal:  Med Image Anal       Date:  2015-11-10       Impact factor: 8.545

9.  Predicting conversion from MCI to AD using resting-state fMRI, graph theoretical approach and SVM.

Authors:  Seyed Hani Hojjati; Ata Ebrahimzadeh; Ali Khazaee; Abbas Babajani-Feremi
Journal:  J Neurosci Methods       Date:  2017-03-09       Impact factor: 2.390

10.  Cortical graph neural network for AD and MCI diagnosis and transfer learning across populations.

Authors:  Chong-Yaw Wee; Chaoqiang Liu; Annie Lee; Joann S Poh; Hui Ji; Anqi Qiu
Journal:  Neuroimage Clin       Date:  2019-07-04       Impact factor: 4.881

View more
  2 in total

1.  Temporal and Spatial Analysis of Alzheimer's Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network.

Authors:  Haijing Sun; Anna Wang; Shanshan He
Journal:  Int J Environ Res Public Health       Date:  2022-04-08       Impact factor: 4.614

Review 2.  Transfer Learning Approaches for Neuroimaging Analysis: A Scoping Review.

Authors:  Zaniar Ardalan; Vignesh Subbian
Journal:  Front Artif Intell       Date:  2022-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.